2024

1. Analysis of the Association between Copy Number Variation and Ventricular Fibrillation in ST-Elevation Acute Myocardial Infarction

   International Journal of Molecular Sciences, Vol. 25, Núm. 5

2. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

   Journal of Cardiac Failure

3. Clinical Relevance of the Systematic Analysis of Copy Number Variants in the Genetic Study of Cardiomyopathies

   Genes, Vol. 15, Núm. 6

4. Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain

   Nefrologia, Vol. 44, Núm. 5, pp. 709-720

5. Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions. Response

   Revista Espanola de Cardiologia

6. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy

   Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349

7. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

   European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615

8. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial

   Progress in Cardiovascular Diseases, Vol. 85, pp. 74-81

9. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

   Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

10. Global Longitudinal Strain as Predictor of Inducible Ischemia in No Obstructive Coronary Artery Disease in the CIAO-ISCHEMIA Study

    Journal of the American Society of Echocardiography, Vol. 37, Núm. 1, pp. 89-99

11. Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry

    European Journal of Heart Failure

12. Impacto del sexo en los tiempos de cateterismo y en el uso de pretratamiento antiagregante plaquetario en pacientes con síndrome coronario agudo sin elevación del segmento ST (SCASEST)

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 2, pp. 123-130

13. Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA

    Circulation, Vol. 150, Núm. 2, pp. 165-167

14. Non-invasive imaging techniques in transcatheter aortic valve implantation

    Cirugia Cardiovascular

15. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

16. Predicting the development of heart failure in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 9, pp. 720-722

17. Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model

    Tissue Engineering and Regenerative Medicine, Vol. 21, Núm. 1, pp. 53-64

18. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

19. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

20. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301